Search alternatives:
mean decrease » a decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
mean decrease » a decrease (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
-
201
Rab7A decreases BST2 cell surface expression and is required for Vpu-induced BST2 cell surface downregulation.
Published 2011“…HeLa cells transfected with either control siRNA (siLuc) or siRNA targeting Rab7A were infected with VSV-G pseudotyped NL4-3 HIV-1 (WT or Udel) at a MOI of 0.5. Twenty-four hours later the cells were stained with mouse monoclonal antibody against BST2 (BST2; upper panels) or control mouse IgG1 as an isotype control (CT IgG; lower panels), along with human anti-Env antibody (2G12). …”
-
202
Twenty-four hour monitoring revealed increased interaction and decreased activity during daytime in <i>Cdkl5</i> -/Y mice.
Published 2018“…The genotype difference during the whole period was not significant (p = 0.791). (B) Mean values in the middle three days. <i>Cdkl5</i> -/Y mice show significant decreases in the number of particles (i) and activity level (ii) during daytime. …”
-
203
-
204
Reducing SIRT1 activity increases, and increasing SIRT1 expression decreases, mitochondrial enzymes in C<sub>2</sub>C<sub>12</sub> myotubes and rat skeletal muscle.
Published 2013“…(D) Overexpression of wild-type (WT) SIRT1 in C<sub>2</sub>C<sub>12</sub> myotubes resulted in decreased cytochrome c protein expression and inhibited the resveratrol (RSV)-induced increase in cytochrome c. …”
-
205
-
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
-
214
Administration of APB5, but not APA5, decreases the hyperplasia of alveolar type 2 epithelial cells induced by BLM.
Published 2018“…The BLM treatment induced hyperplasia and increased the number of SP-C-positive type 2 epithelial cells. The administration of APB5 markedly decreased the hyperplasia of type 2 epithelial cells induced by BLM. …”
-
215
-
216
-
217
B2 decreases glycolytic intermediates in cells.
Published 2025“…The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”
-
218
-
219
-
220